VOLITIONRX LTD — Form SCHEDULE 13D
Filed September 4, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 18/100
What the filing says
Lagoda Investment Management L.P., Lagoda Investment Management LLC, and Fatima Dickey filed a joint Schedule 13D on September 4, 2026, regarding VolitionRx Ltd. common stock (par value $0.001/share). The filing document itself contains only a joint filing agreement with no disclosure of shareholding percentages, share counts, acquisition dates, or beneficial ownership amounts.
Why this rating
Filing is procedurally routine. No material facts disclosed—no share count, ownership %, purchase price, or intended purpose stated. Cannot assess business impact without substantive holdings data.
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.